These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6235402)

  • 41. Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.
    Cappel R; de Cuyper F; De Neef K; Höbel W; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():48-57. PubMed ID: 3898292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The protective action of thymopentin on stress damage to the stomach].
    Deviatkina TA; Tarasenko LM; Klusha VE; Tsebrzhinskiĭ OI; Mutsenietse RK
    Biull Eksp Biol Med; 1989 Jun; 107(6):673-5. PubMed ID: 2676006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymopentin treatment in genital warts of long duration.
    Fransen L; Anthoons J; Hoogewijs G; Bolla K
    Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of recurrent herpes simplex with thymopoietin-pentapeptide].
    Djawari D; Bolla K; Haneke E
    Dtsch Med Wochenschr; 1984 Mar; 109(13):496-8. PubMed ID: 6368167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment with thymopentine of chronic bronchitis in elderly patients during seasonal prophylaxis].
    Santagata A
    Clin Ter; 1990 Feb; 132(4):249-54. PubMed ID: 2140311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results in two infants with the DiGeorge syndrome--effects of long-term TP5.
    Businco L; Rubaltelli FF; Paganelli R; Galli E; Ensoli B; Betti P; Aiuti F
    Clin Immunol Immunopathol; 1986 May; 39(2):222-30. PubMed ID: 3084141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
    Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
    Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymopentin treatment of selective IgA deficiency.
    Fiorilli M; Quinti I; Russi G; Seminara R; Ensoli B; Aiuti F
    Surv Immunol Res; 1985; 4 Suppl 1():129-34. PubMed ID: 3898285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
    Costigliola P; Ricchi E; Colangeli V; Pintori C; Boni P; Chiodo F
    J Exp Pathol; 1987; 3(4):705-12. PubMed ID: 3331653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of an immunomodulating agent on peripheral blood lymphocytes and subgingival microflora in ligature-induced periodontitis.
    Manti F; Kornman K; Goldschneider I
    Infect Immun; 1984 Jul; 45(1):172-9. PubMed ID: 6234232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunomodulators for the prevention of infections in burned guinea pigs.
    Waymack JP; Alexander JW
    J Burn Care Rehabil; 1987; 8(5):363-5. PubMed ID: 3667662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of indomethacin on burn-induced immunosuppression.
    Latter DA; Tchervenkov JI; Nohr CW; Christou NV
    J Surg Res; 1987 Sep; 43(3):246-52. PubMed ID: 3626543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymopentin (TP-5) in the treatment of rheumatoid arthritis.
    Kantharia BK; Goulding NJ; Hall ND; Davies J; Maddison PJ; Bacon PA; Farr M; Wojtulewski JA; Englehart KM; Liyanage SP
    Br J Rheumatol; 1989 Apr; 28(2):118-23. PubMed ID: 2650797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
    Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thymopoietin pentapeptide treatment of primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Rossi P; Seminara R; Goldstein G
    Lancet; 1983 Mar; 1(8324):551-4. PubMed ID: 6131256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
    DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
    Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymic hormone therapy for histiocytosis X?
    Davies EG; Levinsky RJ; Butler M; Broadbent V; Pritchard J; Chessells J
    N Engl J Med; 1983 Aug; 309(8):493-4. PubMed ID: 6348542
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
    Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
    Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.